MedPath

Compact Pneumatic Compression Device for Patients With Lymphedema

Not Applicable
Completed
Conditions
Lymphedema of Limb
Interventions
Device: Monterey Pneumatic Compression Device
Registration Number
NCT04226287
Lead Sponsor
ResMed
Brief Summary

This is a pilot study for usability and efficacy, and as such it is designed for 15 participants.

The primary objective of this study is to assess the usability of the Monterey Investigational System in the home setting.

The primary objective of this study is to assess the usability of the Monterey Investigational System in the home setting over one week of daily use. Usability will be determined using a 11 point Likert Scale where a score of 10 is considered very favorable and a score of 0 is very unfavorable.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
12
Inclusion Criteria
  • Patients who are ≥ 18 years, mentally able to understand and follow the instructions of the study personnel.
  • A diagnosis of lower limb Lymphedema.
  • Able to provide written and informed consent.
  • Patient can read and comprehend English.
Exclusion Criteria
  • Subject undergoing cancer treatment.
  • Subject has active lower limb wounds.
  • Subject is pregnant or trying to become pregnant.
  • History of pulmonary edema or decompensated congestive heart failure.
  • Subject has any condition in which increased venous and lymphatic return is undesirable.
  • Subject has inbuilt electrical stimulator, e.g., cardiac pacemaker

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Monterey Pneumatic Compression DeviceMonterey Pneumatic Compression DeviceAll participants will receive treatment with the Monterey investigational pneumatic compression device
Primary Outcome Measures
NameTimeMethod
Usability of the Monterey Investigational System in a monitored clinic environment1 week

Usability will be determined using a 11 point Likert Scale where a score of 10 is considered very favorable and a score of 0 is very unfavorable.

Secondary Outcome Measures
NameTimeMethod
Efficacy of Therapy provided by Monterey Investigational system1 week

Efficacy will be determined by comparing lower limb volume measured prior to commencing therapy and at the conclusion. The truncated cone formula is a well-established measure used for assessing limb volume \[1\]. The limb is divided into segments as per figure 2, measurements taken and volume in each segment is calculated as per the following formula: Voln = L/12(pi)(C1\^2+C2\^2+C1\*C2)

Trial Locations

Locations (1)

Progressive Physical Therapy and Rehab

🇺🇸

Garden Grove, California, United States

© Copyright 2025. All Rights Reserved by MedPath